Distribution pattern of urine albumin creatinine ratio and the prevalence of high-normal levels in untreated asymptomatic non-diabetic hypertensive patients

Internal Medicine

Volumn 50, Issue 16, 2011, Pages 1621-1629

  Ohmaru, Natsuki ^a   Nakatsu, Takaaki ^b   Izumi, Reishi ^a   Mashima, Keiichi ^b   Toki, Misako ^b   Kobayashi, Asako ^b   Ogawa, Hiroko ^b   Hirohata, Satoshi ^a   Ikeda, Satoru ^a   Kusachi, Shozo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Department of Cardiology   (Japan)

Author keywords

Albumin; Blood pressure; Kidney; Proteinuria; Risk factor

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; JAPANESE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; PULSE PRESSURE; RENAL SYSTEM PARAMETERS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TURBIDIMETRY; URINE ALBUMIN CREATININE RATIO;

ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CREATININE; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE;

EID: 84860394781     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5075     Document Type: Article

References (45)

1. Gerstein HC, Mann JF, Pogue J, et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care 23(Suppl 2): B35-B39, 2000.
2. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Jama 286: 421-426, 2001.
3. Romundstad S, Holmen J, Kvenild K, Hallan H, Ellekjaer H. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis 42: 466-473, 2003.
4. Haffner SM, Stern MP, Gruber MK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 10: 727-731, 1990.
5. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 2: 530-533, 1988.
6. Ritz E. Heart and kidney: fatal twins? Am J Med 119: S31-S39, 2006.
7. Dell'Omo G, Penno G, Giorgi D, Di Bello V, Mariani M, Pedrinelli R. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. Am J Kidney Dis 40: 1-8, 2002.
8. Rachmani R, Levi Z, Lidar M, Slavachevski I, Half-Onn E, Ravid M. Considerations about the threshold value of microalbuminuria in patients with diabetes mellitus: lessons from an 8-year followup study of 599 patients. Diabetes Res Clin Pract 49: 187-194, 2000.
9. Murussi M, Campagnolo N, Beck MO, Gross JL, Silveiro SP. High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study. Diabet Med 24: 1136-1142, 2007.
10. Reboldi G, Gentile G, Angeli F, Verdecchia P. Microalbuminuria and hypertension. Minerva Med 96: 261-275, 2005.
11. Mattix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/ creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 13: 1034-1039, 2002.
12. Summerson JH, Bell RA, Konen JC. Racial differences in the prevalence of microalbuminuria in hypertension. Am J Kidney Dis 26: 577-579, 1995.
13. Chalmers J, MacMahon S, Mancia G, et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 21: 1009-1060, 1999.
14. Hata Y, Mabuchi H, Saito Y, et al. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults. J Atheroscler Thromb 9: 1-27, 2002.
15. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 35: 2-3, 1997.
16. Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis 33: 1004-1010, 1999.
17. Pitt B, Mancini GB, Ellis SG, Rosman HS, Park JS, McGovern ME. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation. J Am Coll Cardiol 26: 1133-1139, 1995.
18. Schectman G, Patsches M, Sasse EA. Variability in cholesterol measurements: comparison of calculated and direct LDL cholesterol determinations. Clin Chem 42: 732-737, 1996.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.
20. Khuu HM, Robinson CA, Goolsby K, Hardy RW, Konrad RJ. Evaluation of a fully automated high-performance liquid chromatography assay for hemoglobin A1c. Arch Pathol Lab Med 123: 763-767, 1999.
21. Kawano K. Quality control, quality assessment of laboratory tests, HbA1c. Southeast Asian J Trop Med Public Health 30 (Suppl 3): 117-121, 1999.
22. Knudsen CW, Omland T, Clopton P, et al. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol 46: 838-844, 2005.
23. Calvino J, Calvo C, Romero R, Gude F, Sanchez-Guisande D. Atherosclerosis profile and microalbuminuria in essential hypertension. Am J Kidney Dis 34: 996-1001, 1999.
24. Rosa TT, Palatini P. Clinical value of microalbuminuria in hypertension. J Hypertens 18: 645-654, 2000.
25. Bakris GL. Microalbuminuria: what is it? Why is it important? What should be done about it? J Clin Hypertens (Greenwich) 3: 99-102, 2001.
26. Ewald B, Attia J. Which test to detect microalbuminuria in diabetic patients? A systematic review. Aust Fam Physician 33: 565- 567, 571, 2004.
27. Tamba S, Nakatsuji H, Kishida K, et al. Relationship between visceral fat accumulation and urinary albumin-creatinine ratio in middle-aged Japanese men. Atherosclerosis 211: 601-605, 2010.
28. Watts GF, Bennett JE, Rowe DJ, et al. Assessment of immunochemical methods for determining low concentrations of albumin in urine. Clin Chem 32: 1544-1548, 1986.
29. Kalaitzidis R, Bakris G. Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road ahead. J Clin Hypertens (Greenwich) 11: 636-643, 2009.
30. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Jensen G. Urinary albumin excretion in a population based sample of 1011 middle aged non-diabetic subjects. The Copenhagen City Heart Study Group. Scand J Clin Lab Invest 53: 867-872, 1993.
31. Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375: 2073-2081, 2010.
32. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19: 1992- 1997, 1999.
33. Parving HH, Mogensen CE, Jensen HA, Evrin PE. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet 1: 1190-1192, 1974.
34. Verdecchia P, Reboldi GP. Hypertension and microalbuminuria: the new detrimental duo. Blood Press 13: 198-211, 2004.
35. Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 16: 1325-1333, 1998.
36. Gatzka CD, Reid CM, Lux A, Dart AM, Jennings GL. Left ventricular mass and microalbuminuria: relation to ambulatory blood pressure. Hypertension Diagnostic Service Investigators. Clin Exp Pharmacol Physiol 26: 514-516, 1999.
37. Pedrinelli R, Dell'Omo G, Penno G, et al. Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men. Hypertension 35: 48-54, 2000.
38. Tsioufis CP, Lambrou SG, Stefanadis CI, et al. Microalbuminuria is associated with abnormal thoracic aortic mechanics in essential hypertension. Am J Cardiol 86: 797-801, A799, 2000.
39. Munakata M, Nunokawa T, Yoshinaga K, Toyota T. Brachial-ankle pulse wave velocity is an independent risk factor for microalbuminuria in patients with essential hypertension-a Japanese trial on the prognostic implication of pulse wave velocity (J-TOPP). Hypertens Res 29: 515-521, 2006.
40. Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 14: 223-228, 1996.
41. Jalal S, Sofi FA, Abass SM, et al. Effect of amlodipine and lisinopril on microalbuminuria in patients with essential hypertension: A prospective study. Indian J Nephrol 20: 15-20, 2010.
42. Agrawal B, Wolf K, Berger A, Luft FC. Effect of antihypertensive treatment on qualitative estimates of microalbuminuria. J Hum Hypertens 10: 551-555, 1996.
43. Ruilope LM, Alcazar JM, Hernandez E, Praga M, Lahera V, Rodicio JL. Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension. Kidney Int Suppl 45: S171-S173, 1994.
44. Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT. The impact of antihypertensive drug groups on urinary albumin excretion in a non-diabetic population. Br J Clin Pharmacol 53: 31-36, 2002.
45. Nakatsu T, Toyonaga T, Mashima K, et al. Cilnidipine reduces the normal to marginally-elevated urine albumin-creatinine ratio independent from its blood pressure-lowering effect in asymptomatic non-diabetic hypertensive patients. Clin Drug Invets 30: 699-706, 2010.